drugset / Trial / NCT00653965

Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)

NCT00653965

Phase 3 Completed 3000 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in Hispanic subjects with hypercholesterolemia

Timeline

Start
2003-05
Primary completion
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule
Subject Rosuvastatin Small molecule

Indications